Date of Publication

2021

Document Type

Bachelor's Thesis

Degree Name

Bachelor of Science in Biology major in Medical Biology

Subject Categories

Other Medical Sciences

College

College of Science

Department/Unit

Biology

Thesis Advisor

Marigold O. Uba

Defense Panel Chair

Ma. Carmen A. Ablan Lagman

Defense Panel Member

Chona Camille V. Abeledo
Mark Christian Felipe R. Redillas

Abstract/Summary

Since the emergence of COVID-19, one of the factors that are being explored is its comorbidities. Hypertension is believed to be among these conditions; however, data and information are limited. This research investigates hypertension as a COVID-19 comorbid condition by assessing the prevalence of hypertension among COVID-19 patients and by analyzing the effect of hypertension on the severity and fatality thereof with the use of the meta-analysis tool, Review Manager 5.4.1. It was found in the 59 studies included that there are at least two (2) patients with hypertension in all cases, suggesting that hypertension is a common COVID-19 comorbid condition. Among COVID-19 patients with hypertension, it was found that there were more males than females. It was also revealed in the meta-analysis that COVID-19 patients with hypertension are 2.89 times more likely to develop a severe form of infection, and are likewise 3.42 times more likely to be a non-survivor. These findings suggest appropriate prioritization of hypertensive patients in terms of COVID-19 prevention and treatment measures. Given the limitations, it is recommended that in further studies, other comorbid conditions be explored and have the inclusion criteria and screening for studies be improved.

Abstract Format

html

Language

English

Format

Electronic

Physical Description

viii, 60 leaves

Keywords

COVID-19 (Disease); Comorbidity; Hypertension

Upload Full Text

wf_yes

Embargo Period

3-27-2022

Download

Share

COinS